Abstract 2648: Comparison of Heparin Plus IIb/IIIa Inhibition Versus Bivalirudin With or Without IIb/IIIa Inhibition in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The ACUITY Trial